Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07690956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pharmacist-Led Education to Improve Neutropenic Precautions in Cancer Patients

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 8, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this clinical trial is to test whether pharmacist-led education can improve knowledge and adherence to neutropenic precautions and reduce infection rates in adult cancer patients receiving high-risk chemotherapy. The main questions it aims to answer are: * Does pharmacist-led education improve patient knowledge of neutropenic fever prevention? * Does it increase adherence to precautionary behaviors? * Does it reduce the incidence of febrile neutropenia? Researchers will compare two groups: one receiving standard care and the other receiving additional education by a clinical pharmacist, to assess the impact on patient behavior and infection outcomes. Participants will: * Receive either standard care or a structured educational intervention that includes written materials, a counseling session, and an instructional video on neutropenic precautions. * Complete knowledge and adherence surveys before and after the intervention. * Be followed for 2-6 months to monitor adherence, infection rates, and treatment outcomes.
Trial Details
NCT Number NCT07690956
Lead Sponsor Jordan University of Science and Technology
Conditions
(from sponsor)		 Febrile Neutropenia
Related terms Febrile Neutropenia
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov